“Global Cellulite Treatment Market to reach a market value of USD 5.4 Billion by 2031 growing at a CAGR of 10.1%”
The Global Cellulite Treatment Market size is expected to reach $5.4 billion by 2031, rising at a market growth of 10.1% CAGR during the forecast period.
Using high-energy acoustic waves, a relatively new treatment option known as acoustic wave therapy targets and targets cellulite in order to break it down. This non-invasive treatment has been shown to improve the appearance of cellulite, reduce skin laxity, and improve overall skin texture. Consequently, the non-invasive would generate approximately 43.0 % share in the market by 2031. These treatments are more effective, safer, and more comfortable than traditional surgical procedures. As a result, more patients opt for these innovative treatments to achieve smoother, firmer, and more youthful-looking skin.
As more individuals become aware of cellulite's impact on their appearance and self-esteem, there has been a corresponding surge in the demand for effective treatments to address this common aesthetic concern. This heightened awareness has been fostered by major international bodies, organizations, and associations dedicated to promoting skin health and raising awareness about cellulite. Hence, the increasing awareness and concern about cellulite have driven the demand for cellulite treatments.
Additionally, As people age, their skin loses elasticity and firmness, making them more prone to cellulite. According to the World Health Organization, one in six people will be 60 or older by 2030. At this time, there will be approximately 1.4 billion people aged 60 or older, a significant increase over the 1 billion projected for 2020. Thus, this demographic trend has increased the demand for cellulite treatments.
However, Cellulite treatments can vary widely in cost depending on the type of treatment and the provider. More advanced or invasive procedures, such as laser therapy or radiofrequency treatments, are more expensive than non-invasive options. Thus, the high cost of effective cellulite treatments may deter their adoption, limiting the market's growth.
Furthermore, The pandemic led to a delay in treatment-seeking behavior among some consumers. Economic uncertainty and concerns about the virus caused some individuals to postpone cosmetic procedures, including cellulite treatments until the situation improves. This delay impacted providers' revenue and led to a backlog of patients seeking treatment. Thus, the pandemic had an overall negative impact on the market.
Based on gender, the market is segmented into male and female. The male segment acquired a 27.05 % revenue share in the market in 2023. Men increasingly seek treatments to improve their appearance and address aesthetic concerns, including cellulite. Additionally, as the stigma surrounding cosmetic procedures diminishes, more men are exploring options to enhance their physical appearance, including reducing the appearance of cellulite. According to the gender breakouts for the 2022 American Society of Plastic Surgeons (ASPS) Procedural Statistics, men accounted for exceptional growth – a 207% rise in total cosmetic procedures since 2019.
On the basis of procedure type, the market is classified into non-invasive, minimally invasive, and topical. The non-invasive segment acquired the 44.14 % revenue share in the market in 2023. Patients are able to return to their regular activities almost immediately after receiving non-invasive treatments because these treatments typically require only a short period of downtime. This convenience attracts those with busy lifestyles who cannot afford extended recovery periods. As technology advances, non-invasive treatments are likely to become even more popular among those looking to improve the appearance of their skin.
Based on cellulite type, the market is characterized into soft cellulite, hard cellulite, and edematous. The edematous segment procured a 15.47 % growth rate in the market in 2023. Edematous cellulite is a type of cellulite characterized by fluid retention and swelling in the affected areas. Hormonal imbalances, poor circulation, and lifestyle factors like diet and exercise are factors that are frequently associated with this condition. The demand for edematous cellulite treatment is on the rise, driven by several factors, including increasing awareness of cellulite as a common concern, the desire for smoother skin, and advancements in treatment options.
By end user, the market is divided into hospitals, clinics & beauty centers, and others. The clinics & beauty centers segment witnessed the 52.27 % revenue share in the market in 2023. Aestheticians, dermatologists, and trained technicians are examples of the types of skilled professionals that are frequently employed by beauty centers and clinics that specialize in the treatment of cellulite. These professionals have extensive experience using these treatments. They may also offer complementary services, such as body contouring and skin tightening treatments, to enhance the results of cellulite reduction procedures.
Free Valuable Insights: Global Cellulite Treatment Market size to reach USD 5.4 Billion by 2031
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment witnessed a 18.45 % growth rate in the market in 2023. Countries such as China, India, and Japan are driving market growth. These countries have large populations with increasing disposable income levels, leading to a growing demand for aesthetic procedures, including cellulite treatments. Additionally, the influence of Western beauty standards and the rise of social media contribute to the growing acceptance of cellulite treatments in these regions.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 2.6 Billion |
| Market size forecast in 2031 | USD 5.4 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 10.1% from 2024 to 2031 |
| Number of Pages | 257 |
| Number of Tables | 430 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Gender, Procedure Type, Cellulite Type, End User, Region |
| Country scope |
|
| Companies Included | Candela Corporation (Syneron Medical), Bausch Health Companies, Inc., Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), AbbVie, Inc., Cynosure, LLC (Clayton, Dubilier & Rice, LLC), Hologic, Inc., Galderma S.A., Zimmer MedizinSysteme GmbH, Endo International PLC, Merz Pharma GmbH & Co. KGaA |
By Gender
By Procedure Type
By Cellulite Type
By End User
By Geography
The Market size is projected to reach USD 5.4 billion by 2031.
Rapidly Growing Aging Population Globally are driving the Market in coming years, however, Considerably High Cost Of Treatments restraints the growth of the Market.
Candela Corporation (Syneron Medical), Bausch Health Companies, Inc., Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), AbbVie, Inc., Cynosure, LLC (Clayton, Dubilier & Rice, LLC), Hologic, Inc., Galderma S.A., Zimmer MedizinSysteme GmbH, Endo International PLC, Merz Pharma GmbH & Co. KGaA
The expected CAGR of this Market is 10.1% from 2024 to 2031.
The Soft Cellulite segment is leading Market by Cellulite Type in 2023 thereby, achieving a market value of $2.5 Billion by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.4 Billion by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 